Medical Educational Resource
We're accelerating the delivery of treatments and cures.
Mitochondrial Disease: Evaluation, Diagnosis and Treatment
Activity Snapshot
Activity Type:
On-Demand Webinar
Release Date:
Thursday, April 6, 2023
Faculty
Amy Goldstein, MD
Clinical Director of the Mitochondrial Medicine Frontier Program
Children’s Hospital of Philadelphia
Activity Overview:
This Grand Rounds webinar, featuring Amy Goldstein, MD, of Children’s Hospital of Philadelphia, will focus on the diagnosis and treatment of mitochondrial disease. Included in this program will be an overview of the diagnosis and evaluation, medical management and care guidelines, and current research.
Learning Objectives:
-
Define the role and function of mitochondria
-
Identify neuromuscular diseases within the mitochondrial disease group, including their mutations
-
Recognize the signs and symptoms of mitochondrial disease, including mitochondrial myopathy
-
Recognize how to optimize medical management of mitochondrial disease
-
Identify treatment options and ongoing research for mitochondrial disease
-
Highlight resources/tools to help streamline diagnosis and referral
Accreditation and Designation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the Muscular Dystrophy Association. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live and enduring formats for this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Live approval period is: March 29, 2023
The Enduring approval period is: April 12, 2023 – April 12, 2024
How to Obtain CME credits :
To obtain instructions to claim CME credit, please email CMEmanagement@mdausa.org.
Faculty Disclosures:
The following planners, speakers, reviewers or staff have relevant financial relationships to disclose:
Full Legal Name: Amy Cheryl Goldstein
Commercial Interest: Reneo Therapeutics, Cyclerion Therapeutics
Role: Consultant
Level of Participation in the Activity: Speaker/Planner-Reviewer
“I have at present or have had within the last 24 months, a financial relationship with one or more ineligible companies.” These financial relationships with ineligible companies have been mitigated by PeerPoint Medical Education Institute and the Muscular Dystrophy Association.
All other presenters, planners, editors, or staff report no relationships to disclose: “I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies.
